Track CBC results, bleeding or bruising, fatigue, infections, triggers, exposures, medicines, transfusions, and specialist follow-up.
Condition detail
Hemophilia
Hemophilia is a blood or clotting condition tracked with CBC or related labs, fatigue, bleeding or bruising, pain episodes when relevant, medicines, transfusions, and specialist follow-up.
Connected records
Database matches for this condition
Antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl
Used for: ALTUVIIIO is indicated for use in adults and pediatric patients with hemophilia A (congenital factor VIII deficiency) for: Routine prophylaxis to reduce the frequency of bleeding episodes On-demand treatment and control of bleeding episodes Perioperative management of bleeding ALTUVIIIO [antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl] is a recombinant DNA-derived, Factor VIII concentrate indicated for use in adults and children with hemophilia A (congenital factor VIII deficiency) for: Routine.
Tranexamic acid
Used for: Tranexamic acid injection, USP is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. Tranexamic acid injection is an antifibrinolytic indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. ( 1 )